1623 Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,994
| Closed | -$508K | – | 27 |
|
|
2022
Q3 | $508K | Hold |
5,994
| – | – | 0.31% | 31 |
|
|
2022
Q2 | $497K | Sell |
5,994
-2,690
| -31% | -$223K | 0.31% | 31 |
|
|
2022
Q1 | $670K | Buy |
8,684
+1,312
| +18% | +$101K | 0.34% | 32 |
|
|
2021
Q4 | $651K | Buy |
7,372
+2,558
| +53% | +$226K | 0.24% | 44 |
|
|
2021
Q3 | $372K | Hold |
4,814
| – | – | 0.15% | 54 |
|
|
2021
Q2 | $402K | Buy |
4,814
+2,962
| +160% | +$247K | 0.15% | 55 |
|
|
2021
Q1 | $140K | Buy |
+1,852
| New | +$140K | 0.06% | 59 |
|